Education
About Us
Working with TipRanks
Follow Us
PharmaSGP Holding SE (DE:PSG)
XETRA:PSG
PSG Stock Chart & Stats
Day’s Range― - ―
52-Week Range€19.00 - €30.00
Previous CloseN/A
Volume202.00
Average Volume (3M)2.38K
Market Cap
€345.60M
Enterprise Value€295.44M
Total Cash (Recent Filing)€37.77M
Total Debt (Recent Filing)€608.00K
Price to Earnings (P/E)17.2
Beta-0.08
Next Earnings
Sep 25, 2025EPS EstimateN/A
Next Dividend Ex-Date
Jun 26, 2025Dividend Yield4.72%
Share Statistics
EPS (TTM)N/A
Shares Outstanding12,000,000
10 Day Avg. Volume3,884
30 Day Avg. Volume2,385
Financial Highlights & Ratios
PEG Ratio2.16
Price to Book (P/B)10.26
Price to Sales (P/S)0.00
P/FCF Ratio13.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€37.63Price Target Upside30.66% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
PharmaSGP Holding SE News
PSG FAQ
What was PharmaSGP Holding SE’s price range in the past 12 months?
PharmaSGP Holding SE lowest stock price was €19.00 and its highest was €30.00 in the past 12 months.
What is PharmaSGP Holding SE’s market cap?
PharmaSGP Holding SE’s market cap is €345.60M.
When is PharmaSGP Holding SE’s upcoming earnings report date?
PharmaSGP Holding SE’s upcoming earnings report date is Sep 25, 2025 which is in 101 days.
How were PharmaSGP Holding SE’s earnings last quarter?
Currently, no data Available
Is PharmaSGP Holding SE overvalued?
According to Wall Street analysts PharmaSGP Holding SE’s price is currently Undervalued.
Does PharmaSGP Holding SE pay dividends?
PharmaSGP Holding SE pays a Annually dividend of €0.509 which represents an annual dividend yield of 4.72%. See more information on PharmaSGP Holding SE dividends here
What is PharmaSGP Holding SE’s EPS estimate?
PharmaSGP Holding SE’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PharmaSGP Holding SE have?
PharmaSGP Holding SE has 12,000,000 shares outstanding.
What happened to PharmaSGP Holding SE’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PharmaSGP Holding SE?
Currently, no hedge funds are holding shares in DE:PSG
PharmaSGP Holding SE Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€37.63 (30.66% Upside)
€37.63 (30.66% Upside)
Insider Transactions
Bought Shares
Worth €32.9M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
39.13%
12-Months-Change
Fundamentals
Return on Equity
48.46%
Trailing 12-Months
Asset Growth
-16.14%
Trailing 12-Months
Company Description
PharmaSGP Holding SE
PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.